Screener
Olema Pharmaceuticals, Inc. OLMA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025. | — | — |
| Common stock, $0.0001 par value; 490,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 87,332,971 and 81,376,449 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | 8 | 8 |
| Additional paid-in capital | 1,131,576 | 1,075,487 |
| Accumulated other comprehensive (loss) income | (460) | 621 |
| Accumulated deficit | (650,646) | (597,557) |
| Total stockholders’ equity | 480,478 | 478,559 |
| Total liabilities and stockholders’ equity | $530,645 | $533,430 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s total equity?
- Olema Pharmaceuticals, Inc. (OLMA) reported total equity of $480.48M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Olema Pharmaceuticals, Inc.'s total equity increased by 25.3% year-over-year, from $383.45M to $480.48M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s total equity has grown at a 7.2% compound annual growth rate (CAGR), from $338.14M to $478.56M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Olema Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude